Emerging Infectious Disease ISSN: 1080-6059

Effectiveness of Pneumococcal Polysaccharide Vaccine for Preschool-Age Children with Chronic Disease

Anthony E. Fiore

, Orin S. Levine, John A. Elliott, Richard R. Facklam, Jay C. Butler, and for the Pneumococcal Sentinel Surveillance Working Group

Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 1

Invasive pneumococcal infections among 173 children ages 2 through 5 years (24-59 months), by serotype. Bottom bar represents proportion of total invasive infections in the cohort caused by each serotype. Top bar depicts cumulative proportion of invasive infections caused by serotypes represented by the bars to the left. Serotypes in the "other" category included 19 serotypes with three or fewer isolates. Two isolates could not be serotyped.

Figure 1. Invasive pneumococcal infections among 173 children ages 2 through 5 years (24-59 months), by serotype. Bottom bar represents proportion of total invasive infections in the cohort caused by each serotype. Top bar depicts cumulative proportion of invasive infections caused by serotypes represented by the bars to the left. Serotypes in the "other" category included 19 serotypes with three or fewer isolates. Two isolates could not be serotyped.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.